Yatharth Hospital & Trauma Care Services Ltd
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
- Market Cap ₹ 5,112 Cr.
- Current Price ₹ 530
- High / Low ₹ 693 / 345
- Stock P/E 39.2
- Book Value ₹ 167
- Dividend Yield 0.00 %
- ROCE 13.8 %
- ROE 10.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 152% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
71 | 78 | 91 | 136 | 215 | 375 | 478 | 635 | 880 | |
53 | 60 | 71 | 98 | 147 | 263 | 343 | 453 | 660 | |
Operating Profit | 18 | 18 | 20 | 38 | 68 | 112 | 135 | 182 | 220 |
OPM % | 25% | 24% | 22% | 28% | 32% | 30% | 28% | 29% | 25% |
0 | 0 | 0 | 0 | 1 | 2 | 3 | 16 | 16 | |
Interest | 6 | 5 | 7 | 20 | 20 | 23 | 23 | 11 | 8 |
Depreciation | 7 | 6 | 8 | 21 | 21 | 28 | 28 | 29 | 57 |
Profit before tax | 5 | 8 | 5 | -2 | 28 | 63 | 88 | 157 | 172 |
Tax % | 41% | 23% | 21% | -18% | 30% | 30% | 25% | 27% | 24% |
3 | 6 | 4 | -2 | 20 | 44 | 66 | 114 | 131 | |
EPS in Rs | 2.21 | 3.75 | 2.43 | -0.79 | 11.09 | 6.74 | 10.04 | 13.33 | 13.55 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 45% |
3 Years: | 33% |
TTM: | 39% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 152% |
3 Years: | 44% |
TTM: | 14% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 16% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 14 | 16 | 16 | 16 | 16 | 66 | 66 | 86 | 96 |
Reserves | 29 | 41 | 39 | 38 | 56 | 51 | 117 | 788 | 1,509 |
85 | 125 | 175 | 194 | 193 | 264 | 267 | 85 | 12 | |
10 | 11 | 26 | 39 | 43 | 45 | 36 | 60 | 114 | |
Total Liabilities | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 |
54 | 53 | 164 | 189 | 251 | 303 | 299 | 442 | 605 | |
CWIP | 64 | 110 | 65 | 62 | 0 | 0 | 0 | 0 | 222 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 |
20 | 30 | 27 | 36 | 58 | 123 | 187 | 577 | 830 | |
Total Assets | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
25 | 17 | 17 | 39 | 44 | 60 | 64 | -3 | 150 | |
-50 | -51 | -78 | -43 | -21 | -52 | -20 | -226 | -420 | |
26 | 43 | 47 | 5 | -19 | -1 | -18 | 304 | 520 | |
Net Cash Flow | 1 | 9 | -13 | 1 | 3 | 7 | 26 | 75 | 249 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 58 | 44 | 48 | 45 | 62 | 83 | 82 | 131 | 125 |
Inventory Days | 47 | 42 | 88 | 72 | 43 | ||||
Days Payable | 127 | 106 | 490 | 347 | 60 | ||||
Cash Conversion Cycle | -22 | -20 | -354 | -229 | 62 | 83 | 82 | 131 | 108 |
Working Capital Days | 44 | 29 | 7 | -11 | 23 | 52 | 79 | 123 | 140 |
ROCE % | 8% | 6% | 7% | 18% | 26% | 27% | 24% | 14% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 Jun
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual Secretarial Compliance Report submitted for FY ended March 31, 2025; no violations reported.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
27 May - Audio recording of Q4 & FY25 earnings call available on company website.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 May - Newspaper publication of the Extracts of Financials Results for the Q4 & FY 25.
-
Re-Appointment Of M/S Deloitte Touche Tohmatsu India LLP As Internal Auditor For The FY 2025-26.
27 May - Re-appointment of Deloitte as internal auditor for FY 2025-26 approved by board.
Concalls
-
Jun 2025Transcript PPT
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
Hospital Portfolio: [1]
- Total Hospitals: 7 hospitals across North India with 87% of the beds in Metro.
Locations and Beds:[2]
- Greater Noida: 400 beds (112 ICU beds, 66% occupancy).
- Noida: 250 beds (81 ICU beds, 83% occupancy).
- Noida Extension: 450 beds (125 ICU beds, 60% occupancy).
- Jhansi-Orchha: 305 beds (76 ICU beds, 47% occupancy).
- Greater Faridabad: 200 beds (61 ICU beds, ramping up at 28% occupancy).